N/A N=36 Randomized Treatment

Nutritional Status and Enteral Absorption Capability After Brain Death

Brain Death

Bottom Line

View on ClinicalTrials.gov: NCT00858390 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Jun 2014

Primary outcome: Primary: Primary Outcome Measure is IL-6 Level — 565.5; 264.9 pg/ml

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: enteral feeding with Oxepa® and Glutasolve® (Dietary_supplement)
Age: Pediatric, Adult, Older Adult · 14+ yrs
Sex: All
Sponsor: The University of Texas Health Science Center, Houston
Primary completion: Aug 2012

Outcome Measures

Outcome	Result	p-value
PRIMARY Primary Outcome Measure is IL-6 Level	565.5; 264.9	—

Summary

The investigators propose to assess 36 donors' nutritional status using accepted parameters (prealbumin, resting energy expenditure); to assess nutrient intestinal absorption through 13Curacil breath tests; and to evaluate serum concentrations of IL-6 and TNFalpha to determine if continuing or initiating enteral feeding and nutritional supplementation is effective in restoring or maintaining nutritional parameters.

Eligibility Criteria

Inclusion Criteria

Consented solid organ donor
Age >14, 60%

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00858390). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.